Copenhagen, Denmark

Daniel E Rasmussen

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 14(Granted Patents)


Location History:

  • Copenhagen, DK (2014 - 2015)
  • København Ø, DK (2015)
  • Koebenhavn OE, DK (2020)

Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Daniel E. Rasmussen

Introduction

Daniel E. Rasmussen is a prominent inventor based in Copenhagen, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of glycoprotein compositions and methods related to coagulation factors. With a total of four patents to his name, his work has advanced the understanding of protein modifications and contaminant reduction in therapeutic compositions.

Latest Patents

Daniel's latest inventions include two noteworthy patents. The first pertains to "O-linked glycoforms of polypeptides and method to manufacture them." This invention focuses on glycoproteins with modified patterns of O-linked glycosylation, particularly targeting Factor VII and Factor IX, alongside methodologies for their production. The second patent, "Reduction of the content of protein contaminants in compositions comprising a vitamin K-dependent protein of interest," addresses the challenge of minimizing protein contaminants in Vitamin K-dependent protein compositions. This innovative approach is especially relevant for preparing coagulation factor compositions, including Factor X, Factor IX, and Factor VII polypeptides.

Career Highlights

Throughout his career, Daniel E. Rasmussen has worked with notable companies in the healthcare sector, including Novo Nordisk Healthcare AG and Novo Nordisk A/S. His expertise in biotech and pharmaceuticals has allowed him to innovate and contribute effectively to the development of critical medical therapies.

Collaborations

Daniel has collaborated with esteemed colleagues such as Janus Krarup and Arne Staby. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of their collective work in the field of biotechnology.

Conclusion

Daniel E. Rasmussen's inventive spirit and dedication to improving medical treatments through biotechnology have positioned him as a noteworthy figure in the realm of innovations. His patents not only reflect his creativity but also signify potential advancements in therapeutic compositions that can benefit patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…